Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ABT will decline by -12.89% over the next 2 Weeks and hit $95.02 by Thursday, February 19, 2026. In that time frame, ABT's share price is expected to range between $91.57 and $98.66.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 19, 2026 | 91.57 | 95.02 | 98.66 |
| Feb 18, 2026 | 94.05 | 97.55 | 101.01 |
| Feb 17, 2026 | 95.68 | 99.22 | 102.50 |
| Feb 16, 2026 | 96.22 | 99.46 | 102.95 |
| Feb 13, 2026 | 97.41 | 100.60 | 103.97 |
| Feb 12, 2026 | 97.95 | 101.20 | 104.58 |
| Feb 11, 2026 | 100.42 | 103.73 | 107.20 |
| Feb 10, 2026 | 102.09 | 105.40 | 108.52 |
| Feb 9, 2026 | 102.48 | 105.64 | 108.89 |
| Feb 6, 2026 | 103.67 | 106.77 | 109.92 |
ABT shares rose +0.81% in Thursday, February 5, 2026's trading session, rising from a previous close of $108.20 to move at $109.08. The stock demonstrated notable intraday movement (see ABT's key stats for a full breakdown), fluctuating between $107.91 and $110.12, a +2.05% trading range. While recent weeks have seen some volatility, ABT has managed to secure a +1.55% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 13.54M shares changing hands, 379.51K more than the previous session. This amounted to $1.48B in total market activity.
Will ABT Continue Its Downward Trend?
According to analyst ratings and projections for ABT, Abbott Laboratories shares are anticipated to decrease by -10.56%, potentially reaching $98.66 per share by February 19, 2026. Short-term technical indicators currently suggest a neutral sentiment for ABT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the ABT stock forecast, now is not the best time to buy ABT stock because its current trading price is +14.79% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ABT covering social and institutional perspectives.
ABT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ABT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 31.97% to 33.66%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 38.44%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.33%, maintains a neutral outlook for the long term. Insights into ABT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Abbott Laboratories Short-Term Forecasts
ABT Forecast For Next 5 Days
Our algorithm anticipates Abbott Laboratories (ABT) stock could hit $104.86 by Feb 12, 2026. This represents a -3.87% fall from today's price, following a -2.81% change over the past five days.
ABT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Abbott Laboratories (ABT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $93.64, which would mean a -14.15% decrease from the current price of $109.08. Projections for this period range from a high of $110.58 to a low of $76.62.
ABT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Abbott Laboratories's price over the next three months point to a rise. ABT stock is expected to peak at $117.24 on May 04, 2026 after potentially dipping to $106.74 on Feb 06, 2026. On average, ABT is likely to trade around $111.98 in the coming 90 days.
Abbott Laboratories Stock Forecast 2025
Based on our predictive models, Abbott Laboratories (ABT) is expected to trade between $106.74 and $122.45 throughout 2026. This would result in an average price of $114.97, potentially offering investors a +5.40% return from current levels.
Abbott Laboratories Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Abbott Laboratories (ABT) is positioned to show a strong performance in February 2026. The price is predicted to move between $106.74 and $114.78, settling at an average of $110.82. This could translate to a +1.60% gain.
March 2026
Based on current market signals, Abbott Laboratories is projected to trend march 2026. We forecast a trading range from $108.62 to $116.19, with a likely average price of $112.04. Investors could expect a potential return of +2.71%.
April 2026
Our predictive algorithms indicate Abbott Laboratories stock may see a shift in April 2026. The expected range spans $107.43–$117.21, with an average target of $112.33. This represents a positive outlook and a possible gain of +2.98%.
May 2026
Analyzing established trends, Abbott Laboratories looks set to move in May 2026. Projections place the stock between $110.73 and $117.44, averaging around $114.25. This suggests a +4.74% gain from current levels.
June 2026
Market indicators suggest Abbott Laboratories could experience notable changes during June 2026. Prices could fluctuate within $107.82 to $117.88, with a midpoint forecast of $113.15. The stock might deliver a +3.73% gain.
July 2026
Forecasting for July 2026, models estimate that Abbott Laboratories may undergo key fluctuations. If trends hold, the stock might trade between $109.23 and $119.17, averaging $114.40. This signals a positive trajectory with potential returns around +4.88%.
August 2026
According to our latest forecast models, Abbott Laboratories (ABT) is positioned to show a strong performance in August 2026. The price is predicted to move between $112.70 and $119.75, settling at an average of $116.18. This could translate to a +6.51% gain.
September 2026
Based on current market signals, Abbott Laboratories is projected to trend september 2026. We forecast a trading range from $111.55 to $121.46, with a likely average price of $116.55. Investors could expect a potential return of +6.85%.
October 2026
Our predictive algorithms indicate Abbott Laboratories stock may see a shift in October 2026. The expected range spans $111.84–$122.07, with an average target of $118.20. This represents a positive outlook and a possible gain of +8.36%.
November 2026
Analyzing established trends, Abbott Laboratories looks set to move in November 2026. Projections place the stock between $111.81 and $121.71, averaging around $116.83. This suggests a +7.10% gain from current levels.
December 2026
Market indicators suggest Abbott Laboratories could experience notable changes during December 2026. Prices could fluctuate within $113.01 to $122.45, with a midpoint forecast of $118.75. The stock might deliver a +8.87% gain.
January 2027
Forecasting for January 2027, models estimate that Abbott Laboratories may undergo key fluctuations. If trends hold, the stock might trade between $116.66 and $123.61, averaging $120.20. This signals a positive trajectory with potential returns around +10.19%.
February 2027
According to our latest forecast models, Abbott Laboratories (ABT) is positioned to show a strong performance in February 2027. The price is predicted to move between $115.33 and $122.09, settling at an average of $118.78. This could translate to a +8.89% gain.
ABT's history of dividends and stock splits also plays a role in long-term investor confidence.

